Research Projects Page

Since our inception as an outcome committee in 2015, we have consistently and considerably expanded our ability to produce rigorous outcomes research. In 2018, we established a more formal program and leadership, including full time outcomes research staff. The result of these allocated resources has been a productive output across multiple specialty disease states. Below are highlighted outcomes from studies completed in recent years.

Research Project List

Research categories (field_research_categories)
Research categories (field_research_categories)
21-30 of 115 results

Universal Hepatitis C Virus Screening in a Tennessee Tertiary Care Emergency Department

This podium presentation details how universal Hepatitis C virus screening in tertiary care center emergency department identified a high rate and volume of HCV + individuals, and how screening in emergency departments may assist in identifying certain at-risk groups that may not be screened in other settings.

Development and Implementations of a Laboratory Monitoring Dashboard to Reduce Therapy Gaps in Inflammatory Bowel Disease

The objective of this study was to evaluate the implementation of a dashboard to prevent therapy gaps by prospectively identifying patients on biologic therapy needing a new prescription with outdated labs. The new dashboard was highly effective at reducing the number of patients with a therapy gap, number of gap days, and days to receipt of a new prescription. Pharmacists and nurses reported high satisfaction rates with the new dashboard.

Using Technology to Drive Patient Care

This podium presentation lists challenges in specialty pharmacy medication management and describes targeted support that could be provided to patients to lessen their risk for poor outcomes.

Management of Patients with Multiple Sclerosis within Health-System Specialty Pharmacies: Pharmacist Actions

This multisite, prospective, cohort study of patients with MS evaluates the frequency and type of pharmacists' actions for patients on DMTs for MS across four HSSP sites. This study demonstrates that pharmacists commonly perform actions related to providing medication education and ensuring DMT safety and adherence.

Retraining of Transplant Pharmacy Staff to Reduce Medicare Part B Prescription Billing Errors in Post-Transplant Recipients

Because MedB billing error fines can be costly for pharmacies dispensing high-cost medications, identifying common errors and training staff can be useful and financially prudent. The aim of this quality improvement project was to retrain certified pharmacy technicians (CPhTs) on common monthly billing errors and evaluate changes in error rates and potential fines.

Implementation of a Standardized Specialty Pharmacist Documentation Tool Within the Electronic Health Record in an Integrated Outpatient Dermatology Clinic

We implemented a standardized documentation tool (SmartForms) that would collect discrete data fields during the specialty pharmacist's workflow in Dermatology clinic. This allowed us to collect data for reporting purposes on the front end, save time, document pharmacist interventions prior to treatment initiation, improve Epic documentation visibility and future usability.

Hepatitis C Cascade of Care in a Multidisciplinary Substance Use Bridge Clinic Model

The objective of this study was to characterize the HCV cascade of care in a bridge clinic setting and identify barriers to HCV treatment in this population. This study demonstrated that several challenges and barriers exist to engage patients in HCV care in a bridge clinic model, and more strategies should be identified to engage patients and link them to care.

Persistence on Droxidopa for the Management of Orthostatic Hypotension at an Integrated Care Center

This was a single-center, retrospective analysis of persistence on droxidopa for the management of orthostatic hypotension in adults patients. This study also evaluated adherence, patient-reported adverse events and falls as well as healthcare resource utilization.

Financial impact of integrated specialty pharmacy efforts to avoid oral oncolytic waste

This study highlights how specialty pharmacists with access to patient medical records were able to postpone requesting oral anticancer medication refills for patients with upcoming follow-up and sufficient medication on hand. Therapy was discontinued or changed in 98% of postponed requests accounting for over $967,000 in costs avoided.

Patient-centered monitoring for encorafenib and binimetinib: Tailoring patient education, monitoring, and outreach to improve health outcomes

The purpose of this project was to assess the type and frequency of AEs and AE-associated medical actions (i.e., treatment holds, dose reduction and treatment discontinuation due to AEs) in patients initiating encorafenib and binimetinib combination therapy.